ArticlePloS one2013

The availability of a functional tumor targeting T-cell repertoire determines the anti-tumor efficiency of combination therapy with anti-CTLA-4 and anti-4-1BB antibodies.

Benjamin A H Jensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.